Chen H, Dong K, Ding J, Xia J, et al. CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression. Cancer Lett 2024 Feb 14:216725. doi: 10.1016/j.canlet.2024.216725.
PMID: 38364963